Need answers? 1·800·227·2345 | Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


Cancer Reference Information
 
    All About This Topic
Other Information Sources
Glossary
Cancer Drug Guide
Treatment Options
Treatment Decision Tools
   
Detailed Guide: Myelodysplastic Syndrome
Growth Factors

Hematopoietic growth factors are hormone-like substances that stimulate bone marrow to produce blood cells. Although these substances occur naturally in the body, scientists have found a way to make them outside of the body in large amounts. This allows patients to receive these factors in larger doses than would be produced by their own body.

Shortages of blood cells cause most of the symptoms in people with MDS, and growth factors can help the blood counts to become more normal. The growth factors granulocyte colony stimulating factor (G-CSF, neupogen, or filgrastim) and granulocyte macrophage-colony stimulating factor (GM-CSF or sargramostim) can improve white blood cell production. These can benefit some MDS patients whose main problem is a shortage of white blood cells and are suffering from frequent infections. Pegfilgrastim (Neulasta) is a long-acting form of G-CSF. It works in the same way, but can be given less often.

Erythropoietin (Epo or Procrit), a growth factor that promotes red blood cell production, can help avoid red blood cell transfusions in some patients. Recently it has been found that combining erythropoietin with G-CSF improves the patient’s response to the erythropoietin. Darbepoetin alfa (Aranesp) is a long-acting form of erythropoietin. It works in the same way, but can be given less often.

A drug called oprelvekin (Neumega, interleukin-11, or IL-11) can be used to stimulate platelet production after chemotherapy and in some other diseases. This drug can help increase the platelet counts of some MDS patients for a time, but then the counts go back down again. For most MDS patients, this drug is not very helpful.

More studies are under way to find the best way to predict which patients will benefit from growth factors and the best way to combine growth factors with each other and with other treatments, such as chemotherapy or hormones. Patients usually receive the growth factors through subcutaneous (under the skin) injections. Your health care team can give the injections, or you or your family members can learn to give them.

Androgens, or male hormones, can boost blood cell production that is abnormally low due to certain diseases. A few people with MDS may be helped by androgens, but most do not improve. If no other treatment options are appropriate for a patient, some doctors recommend trying androgens. However, these hormones can cause side effects, such as liver problems or muscle cramps. In women, androgens can produce male features, such as growth of facial and body hair, and can increase the sex drive.

Last Revised: 12/07/2006

Printer-Friendly Page
Email this Page
Overview
Detailed Guide
What Is It?
Causes, Risk Factors and Prevention
Early Detection, Diagnosis, Staging
Treating Myelodysplastic Syndrome
Talking With Your Doctor
More Information
Related Tools & Topics
Prevention & Early Detection  
Bookstore  
Circle Of Sharing: Personalize Your Cancer Information  
Not registered yet?
  Register now or see reasons to register.  
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2010 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.